IBDEI0VG ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15280,0)
 ;;=907.2^^81^941^74
 ;;^UTILITY(U,$J,358.3,15280,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15280,1,4,0)
 ;;=4^907.2
 ;;^UTILITY(U,$J,358.3,15280,1,5,0)
 ;;=5^Late Effect of SCI
 ;;^UTILITY(U,$J,358.3,15280,2)
 ;;=^275240
 ;;^UTILITY(U,$J,358.3,15281,0)
 ;;=V12.54^^81^941^72
 ;;^UTILITY(U,$J,358.3,15281,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15281,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,15281,1,5,0)
 ;;=5^Hx of Stroke w/o Residuals
 ;;^UTILITY(U,$J,358.3,15281,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,15282,0)
 ;;=438.10^^81^941^14
 ;;^UTILITY(U,$J,358.3,15282,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15282,1,4,0)
 ;;=4^438.10
 ;;^UTILITY(U,$J,358.3,15282,1,5,0)
 ;;=5^CVA w/Language (late effect)
 ;;^UTILITY(U,$J,358.3,15282,2)
 ;;=^317906
 ;;^UTILITY(U,$J,358.3,15283,0)
 ;;=438.11^^81^941^3
 ;;^UTILITY(U,$J,358.3,15283,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15283,1,4,0)
 ;;=4^438.11
 ;;^UTILITY(U,$J,358.3,15283,1,5,0)
 ;;=5^CVA w/Aphasia (late effect)
 ;;^UTILITY(U,$J,358.3,15283,2)
 ;;=^317907
 ;;^UTILITY(U,$J,358.3,15284,0)
 ;;=438.13^^81^941^6
 ;;^UTILITY(U,$J,358.3,15284,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15284,1,4,0)
 ;;=4^438.13
 ;;^UTILITY(U,$J,358.3,15284,1,5,0)
 ;;=5^CVA w/Dysarthria (late effect)
 ;;^UTILITY(U,$J,358.3,15284,2)
 ;;=^338239
 ;;^UTILITY(U,$J,358.3,15285,0)
 ;;=438.14^^81^941^10
 ;;^UTILITY(U,$J,358.3,15285,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15285,1,4,0)
 ;;=4^438.14
 ;;^UTILITY(U,$J,358.3,15285,1,5,0)
 ;;=5^CVA w/Fluency (late effect)
 ;;^UTILITY(U,$J,358.3,15285,2)
 ;;=^338240
 ;;^UTILITY(U,$J,358.3,15286,0)
 ;;=438.30^^81^941^20
 ;;^UTILITY(U,$J,358.3,15286,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15286,1,4,0)
 ;;=4^438.30
 ;;^UTILITY(U,$J,358.3,15286,1,5,0)
 ;;=5^CVA w/Monoplegia Upper Arm (late effect)
 ;;^UTILITY(U,$J,358.3,15286,2)
 ;;=^317913
 ;;^UTILITY(U,$J,358.3,15287,0)
 ;;=438.31^^81^941^16
 ;;^UTILITY(U,$J,358.3,15287,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15287,1,4,0)
 ;;=4^438.31
 ;;^UTILITY(U,$J,358.3,15287,1,5,0)
 ;;=5^CVA w/Monoplegia Dominant Upper Arm
 ;;^UTILITY(U,$J,358.3,15287,2)
 ;;=^317914
 ;;^UTILITY(U,$J,358.3,15288,0)
 ;;=438.32^^81^941^19
 ;;^UTILITY(U,$J,358.3,15288,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15288,1,4,0)
 ;;=4^438.32
 ;;^UTILITY(U,$J,358.3,15288,1,5,0)
 ;;=5^CVA w/Monoplegia Nondominant Upper Arm
 ;;^UTILITY(U,$J,358.3,15288,2)
 ;;=^317915
 ;;^UTILITY(U,$J,358.3,15289,0)
 ;;=438.40^^81^941^17
 ;;^UTILITY(U,$J,358.3,15289,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15289,1,4,0)
 ;;=4^438.40
 ;;^UTILITY(U,$J,358.3,15289,1,5,0)
 ;;=5^CVA w/Monoplegia Lower Limb,Unspec
 ;;^UTILITY(U,$J,358.3,15289,2)
 ;;=^317916
 ;;^UTILITY(U,$J,358.3,15290,0)
 ;;=438.41^^81^941^15
 ;;^UTILITY(U,$J,358.3,15290,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15290,1,4,0)
 ;;=4^438.41
 ;;^UTILITY(U,$J,358.3,15290,1,5,0)
 ;;=5^CVA w/Monoplegia Dominant Lower Limb
 ;;^UTILITY(U,$J,358.3,15290,2)
 ;;=^317917
 ;;^UTILITY(U,$J,358.3,15291,0)
 ;;=438.42^^81^941^18
 ;;^UTILITY(U,$J,358.3,15291,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15291,1,4,0)
 ;;=4^438.42
 ;;^UTILITY(U,$J,358.3,15291,1,5,0)
 ;;=5^CVA w/Monoplegia Nondominant Lower Limb
 ;;^UTILITY(U,$J,358.3,15291,2)
 ;;=^317918
 ;;^UTILITY(U,$J,358.3,15292,0)
 ;;=438.50^^81^941^24
 ;;^UTILITY(U,$J,358.3,15292,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15292,1,4,0)
 ;;=4^438.50
 ;;^UTILITY(U,$J,358.3,15292,1,5,0)
 ;;=5^CVA w/Oth Paralysis,Unspec
 ;;^UTILITY(U,$J,358.3,15292,2)
 ;;=^317919
 ;;^UTILITY(U,$J,358.3,15293,0)
 ;;=438.51^^81^941^21
 ;;
 ;;$END ROU IBDEI0VG
